{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:54:52Z","timestamp":1782626092038,"version":"3.54.5"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,30]]},"abstract":"<jats:p>Axillary staging is 1 of the major issues of current breast cancer management after neoadjuvant systemic therapy (NST). Sentinel lymph node biopsy (SLNB) is an option for clinically node negative patients. Axillary reverse mapping (ARM) was introduced to identify and preserve the lymphatic drainage from the arm. The aim of the presented study is to employ triple mapping (radiocolloid, blue dye and indocyanine green [ICG]) to assess the crossover rate and metastatic involvement of ARM nodes after NST. Clinically node positive patients before NST who were converted to N0 and scheduled for targeted axillary dissection were included. sentinel lymph node (SLN) mapping was performed via dual agent mapping. ICG was used for ARM procedure. Blue, hot and fluorescent nodes and lymphatics were visualized in the axilla using infrared camera system and dual opto-nuclear probe (Euoroprobe3). Fifty-two patients underwent targeted axillary dissection and ARM procedures 12 out of whom had axillary node dissection. 45 of the 52 patients had at least 1 hot or blue SLN identified intraoperatively. Of these, 61.5% cases had hot SLNs, 42.3% had hot and blue, 15.4% had hot\/blue\/fluorescent, 7.7% had blue\/fluorescent, 6 11.5% had hot\/fluorescent and 7 13.5% had only clipped nodes. The overall identification rate of ARM-nodes by means of ICG technique was 86.5%. Overall crossover of ARM nodes with SLNs was determined in 36.5%. The ICG intensity was found to be higher in both hot and blue SLNS (8 out of 18 ICG positive cases, 44.4%). In 3 of 52 patients (5.7%) metastatic SLNs were hot or blue but fluorescent which predicts metastatic involvement of the ARM-nodes. More than 1-third of the patients revealed a crossover between arm and breast draining nodes. The higher observed rate of overlap might partially explain why more patients develop clinically significant lymphedema after NST even after sentinel lymph node biopsy alone. The triple mapping provides valuable data regarding the competency of lymphatic drainage and would have the potential to serve selecting patients for lymphovenous by-pass procedures at the index procedure. NST reduces the metastatic involvement of the ARM nodes. However, conservative axillary staging with sparing ARM nodes after NST necessitates further studies with larger sample size and longer follow-up.<\/jats:p>","DOI":"10.1097\/md.0000000000032545","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T13:01:54Z","timestamp":1672405314000},"page":"e32545","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy"],"prefix":"10.1097","volume":"101","author":[{"given":"Ilhan","family":"Tasdoven","sequence":"first","affiliation":[{"name":"Zonguldak Bulent Ecevit University, School of Medicine, Department of General Surgery, Zonguldak, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Balbaloglu","sequence":"additional","affiliation":[{"name":"Zonguldak Bulent Ecevit University, School of Medicine, Department of General Surgery, Zonguldak, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5542-7453","authenticated-orcid":false,"given":"Rabiye Uslu","family":"Erdemir","sequence":"additional","affiliation":[{"name":"Zonguldak Bulent Ecevit University, School of Medicine, Department of Nuclear Medicine, Zonguldak, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Bahadir","sequence":"additional","affiliation":[{"name":"Zonguldak Bulent Ecevit University, School of Medicine, Department of Clinical Pathology, Zonguldak, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cakmak","family":"Guldeniz Karadeniz","sequence":"additional","affiliation":[{"name":"Zonguldak Bulent Ecevit University, School of Medicine, Department of General Surgery, Zonguldak, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1245\/ASO.2006.05.013","article-title":"Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.","volume":"13","author":"Wilke","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0142(20010815)92:4<748::AID-CNCR1378>3.0.CO;2-V","article-title":"Lymphedema after sentinel lymphadenectomy for breast carcinoma.","volume":"92","author":"Sener","year":"2001","journal-title":"Cancer"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated withsentinel lymph node dissection (SLND) plus axillary lymph nodedissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.","volume":"25","author":"Lucci","year":"2007","journal-title":"J Clin Oncol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1245\/s10434-007-9412-x","article-title":"Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation.","volume":"14","author":"Thompson","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1245\/s10434-007-9450-4","article-title":"Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.","volume":"14","author":"Nos","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R6-20250504","first-page":"563","article-title":"A new concept toward the prevention of lymphedema: axillary reverse mapping.","volume":"97","author":"Klimberg","year":"2008","journal-title":"J Surg Ocol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/01.prs.0000246516.64780.61","article-title":"The lymphatic territories of the upper limb: anatomical study and clinical implications.","volume":"119","author":"Suami","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1245\/s10434-012-2363-x","article-title":"Relationship between the lymphatic drainage of the breast and the upper extremity: a postmortem study.","volume":"19","author":"Pavlista","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Alliance for Clinical Trials in Oncology. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"suppl","key":"R10-20250504","first-page":"1018abstr 1018","article-title":"Sentinel node biopsy following neoadjuvant chemotherapy in biopsy proven node positive breast cancer: the SN FNAC Study.","volume":"31","author":"Boileau","year":"2013","journal-title":"J Clin Oncol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/S1470-2045(13)70590-4","article-title":"Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review.","volume":"15","author":"Ahmed","year":"2014","journal-title":"Lancet Oncol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jso.21473","article-title":"Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer.","volume":"101","author":"Noguchi","year":"2010","journal-title":"J Surg Oncol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ejso.2016.02.244","article-title":"Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer.","volume":"42","author":"Noguchi","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12282-021-01300-6","article-title":"The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer.","volume":"29","author":"Noguchi","year":"2022","journal-title":"Breast Cancer"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jso.24859","article-title":"Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.","volume":"117","author":"Foster","year":"2018","journal-title":"J Surg Oncol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"59e","DOI":"10.1016\/j.ejso.2014.09.012","article-title":"Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.","volume":"41","author":"Beek","year":"2015","journal-title":"EJSO"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, openlabel, phase 3 non-inferiority trial.","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jamcollsurg.2007.12.022","article-title":"Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.","volume":"206","author":"Boneti","year":"2008","journal-title":"J Am Coll Surg"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-009-0578-8","article-title":"Axillary reverse mapping for breast cancer.","volume":"119","author":"Noguchi","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"e0150285","DOI":"10.1371\/journal.pone.0150285","article-title":"The feasibility and oncological safety of axillary reverse mapping in patients with Breast cancer: a systematic review and meta-analysis of prospective studies.","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/lrb.2006.4.42","article-title":"Addressing the unmet needs in lymphedema risk management.","volume":"4","author":"Rockson","year":"2006","journal-title":"Lymphat Res Biol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1196\/annals.1413.014","article-title":"Estimating the population burden of lymphedema.","volume":"1131","author":"Rockson","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejso.2015.01.029","article-title":"Is axillary reverse mapping feasible in breast cancer patients?","volume":"41","author":"Noguchi","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejso.2014.03.023","article-title":"The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.","volume":"40","author":"Ikeda","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/cncr.25096","article-title":"A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.","volume":"116","author":"Bedrosian","year":"2010","journal-title":"Cancer"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jso.24231","article-title":"Axillary reverse mapping in patients with breast cancer: is it oncologically safe?","volume":"113","author":"Ngui","year":"2016","journal-title":"J Surg Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:25:48Z","timestamp":1746332748000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":28,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032545","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}